Liposomal extended-release bupivacaine for postsurgical analgesia

When physicians consider which analgesia to use postsurgery, the primary goal is to relieve pain with minimal adverse side effects. Bupivacaine, a commonly used analgesic, has been formulated into an aqueous suspension of multivesicular liposomes that provide long-lasting analgesia for up to 72 hour...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambrechts, Mark, O’Brien, Michael J, Savoie, Felix H, You, Zongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772762/
https://www.ncbi.nlm.nih.gov/pubmed/24043932
http://dx.doi.org/10.2147/PPA.S32175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772762/
https://www.ncbi.nlm.nih.gov/pubmed/24043932
http://dx.doi.org/10.2147/PPA.S32175

Ejemplares similares